Merendino et al. 36 reported that serum MDA levels were an index of inflammation and oxidative stress in BPH patients, and there was a positive correlation between prostate-specific antigen (a marker of prostatic hyperplasia and prostate cancer) and MDA levels. The gene discussed is KLK3; the disease is benign prostatic hyperplasia.